REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 1,000 | -99.6% | 0.00% | – |
| Q4 2014 | $176,000 | -83.6% | 251,849 | -79.6% | 0.00% | – |
| Q2 2014 | $1,075,000 | +176.3% | 1,235,989 | +242.8% | 0.00% | – |
| Q1 2014 | $389,000 | +2188.2% | 360,604 | +1024.5% | 0.00% | – |
| Q4 2013 | $17,000 | – | 32,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 20,000 | $57,000 | 0.02% |